Lexaria Bioscience Corp (LEXX)
3.45
+0.02
(+0.58%)
USD |
NASDAQ |
May 08, 15:31
Lexaria Bioscience 1 Year Total Returns (Daily): 161.8% for May 7, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 07, 2024 | 161.8% |
| May 06, 2024 | 160.3% |
| May 03, 2024 | 93.21% |
| May 02, 2024 | 61.29% |
| May 01, 2024 | 87.63% |
| April 30, 2024 | 47.85% |
| April 29, 2024 | 17.70% |
| April 26, 2024 | 3.98% |
| April 25, 2024 | -0.45% |
| April 24, 2024 | -2.65% |
| April 23, 2024 | -1.32% |
| April 22, 2024 | -0.22% |
| April 19, 2024 | -1.79% |
| April 18, 2024 | -0.44% |
| April 17, 2024 | 7.83% |
| April 16, 2024 | 5.96% |
| April 15, 2024 | -8.72% |
| April 12, 2024 | -7.02% |
| April 11, 2024 | 7.96% |
| April 10, 2024 | 13.19% |
| April 09, 2024 | 13.92% |
| April 08, 2024 | 24.89% |
| April 05, 2024 | 31.18% |
| April 04, 2024 | 33.47% |
| April 03, 2024 | 26.94% |
| Date | Value |
|---|---|
| April 02, 2024 | 27.57% |
| April 01, 2024 | 25.74% |
| March 28, 2024 | 46.37% |
| March 27, 2024 | 44.92% |
| March 26, 2024 | 51.60% |
| March 25, 2024 | 58.00% |
| March 22, 2024 | 40.28% |
| March 21, 2024 | 36.51% |
| March 20, 2024 | 46.25% |
| March 19, 2024 | 56.86% |
| March 18, 2024 | 33.33% |
| March 15, 2024 | 43.91% |
| March 14, 2024 | 37.99% |
| March 13, 2024 | 48.15% |
| March 12, 2024 | 42.18% |
| March 11, 2024 | 112.6% |
| March 08, 2024 | 67.17% |
| March 07, 2024 | 49.25% |
| March 06, 2024 | 29.11% |
| March 05, 2024 | 7.99% |
| March 04, 2024 | -4.15% |
| March 01, 2024 | -1.35% |
| February 29, 2024 | 13.86% |
| February 28, 2024 | -15.84% |
| February 27, 2024 | -20.69% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-79.66%
Minimum
Mar 18 2020
161.8%
Maximum
May 07 2024
-45.47%
Average
-51.67%
Median
Aug 26 2022
1 Year Total Returns (Daily) Benchmarks
| Aurinia Pharmaceuticals Inc | -55.71% |
| Sunshine Biopharma Inc | -98.07% |
| Acasti Pharma Inc | 5.70% |
| Edesa Biotech Inc | -39.08% |
| Xenon Pharmaceuticals Inc | 2.40% |